Chemotherapy, AdjuvantRadiotherapyRadiotherapy, AdjuvantRadiotherapy DosageCombined Modality TherapyAdjuvants, ImmunologicRadiotherapy, ConformalBreast NeoplasmsNeoplasm Recurrence, LocalRadiotherapy, Intensity-ModulatedTreatment OutcomeDisease-Free SurvivalAdjuvants, PharmaceuticNeoplasm StagingRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyAntineoplastic Combined Chemotherapy ProtocolsFluorouracilTamoxifenSurvival AnalysisAntineoplastic Agents, HormonalFreund's AdjuvantPrognosisDose FractionationRadiation InjuriesSurvival RateRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedLymphatic MetastasisFollow-Up StudiesLevamisoleRetrospective StudiesAntineoplastic AgentsBrachytherapyCyclophosphamideMastectomyRectal NeoplasmsAdenocarcinomaRadiation OncologyLeucovorinAromatase InhibitorsNeoadjuvant TherapyBrain NeoplasmsCisplatinTime FactorsLung NeoplasmsKaplan-Meier EstimateMethotrexateCarcinoma, Squamous CellRandomized Controlled Trials as TopicRadiosurgeryClinical Trials as TopicColonic NeoplasmsHead and Neck NeoplasmsDose-Response Relationship, RadiationDrug Administration ScheduleNeoplasms, Second PrimaryMastectomy, SegmentalDoxorubicinChemoradiotherapyReceptors, EstrogenNeoplasm MetastasisProspective StudiesLymph Node ExcisionAntimetabolites, AntineoplasticEpirubicinNasopharyngeal NeoplasmsProportional Hazards ModelsNitrilesRadiation ToleranceTumor Markers, BiologicalVincristineLymph NodesTriazolesMultivariate AnalysisMedical OncologyPostmenopauseOrgans at RiskOrganoplatinum CompoundsAnthracyclinesCarcinomaRadiation-Sensitizing AgentsPostoperative CareSarcomaAntineoplastic Agents, AlkylatingRecurrenceQuality of LifeColorectal NeoplasmsGoserelinNeoplasm InvasivenessCarcinoma, Non-Small-Cell LungReceptor, erbB-2Particle AcceleratorsMelanomaCranial IrradiationPancreatic NeoplasmsChemoradiotherapy, AdjuvantNeoplasmsProstatic NeoplasmsPremenopause